Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
Although type 1 and type 2 diabetes have a huge impact on millions of people worldwide, there is still no cure for either condition. In diabetes, blood sugar levels are dysregulated. If untreated, high levels of blood sugar cause a range of symptoms that can have severe long-term effects. While treatments nowadays can help diabetics manage their symptoms, patients still face many long-term health complications.
Moreover, estimations suggest that the number of people affected by diabetes is steadily increasing worldwide. As a result, the World Health Organization considers diabetes an epidemic. Read on to gather more information about diabetes and how researchers are working on tackling the disease.
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to Report
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
Evotec and Sernova are set to join forces to advance a beta cell replacement therapy…
Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science…
Will the daily routine of finger pricking to monitor blood sugar levels finally come to…
As French biotech Poxel marks the first market approval of its oral type 2 diabetes…
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their…
In Stockholm, Sweden, Sigrid Therapeutics is developing an ingestible silica powder that can treat type…
In a deal worth up to €67M, industry giant Nestlé Health Science will have the…
A genetic mutation common to Finnish populations has been found to protect against type 2…
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…